Mainfreight Limited/Announcement
Mainfreight Limited logo

Mainfreight – Half Year 2018 Presentation

Half Year Results14 November 2017MFTIndustrials

MAINFREIGHT LIMITEDHALF YEAR RESULTTO SEPTEMBER 2017

Result Summary
Revenue

 

up

 

7.3%

 

to

 

$1.23

 

billion

Foreign

 

exchange

 

effect

 

negligible

An

 

increase

 

of

 

$83.15

 

million

EBITDA

 

at

 

$88.77

 

million,

 

up

 

2.8%

An

 

increase

 

of

 

$2.42

 

million

Net

 

surplus

 

after

 

tax

 

before

 

abnormal

 

items

 

up

 

1.1%

 

to

 

$42.77

 

million

Trading

 

through

 

October,

 

and

 

into

 

November

 

reflects

 

further

 

financial

 

improvements

 

and

 

we

 

expect

 

this

 

to

 

continue

 

with

 

strong

 

pre


Christmas

 

volumes

 

across

 

the

 

global

 

network

REVENUEREVENUE

EBITDAEBITDA

NET

 

SURPLUS

NET

 

SURPLUS

OUTLOOKOUTLOOK

Dividend
Interim

 

dividend

 

of

 

19.0

 

cents

 

per

 

share

Books

 

close

 

8 December

 

2017;

 

payment

 

on

 

15

 

December

 

2017

2.0

 

cent

 

increase

 

on

 

prior

 

year’s

 

interim

 

dividend

 

reflects

 

profitability

 

and

 

confidence

 

for

 

full

 

year

 

result

DIVIDENDDIVIDEND

Capital Management
NZ$

 

MILLION

THIS

 

YEAR

LAST

 

YEAR

Operating

 

cash

 

flow

57.15

52.03


Net

 

capital

 

expenditure

 

totalled

 

$32.34

 

million;

 

of

 

which

 

$7.68

 

million

 

is

 

property

 

development,

 

$11.0

 

million

 

is

 

software

 

development,

 

and

 

the

 

balance

 

plant

 

and

 

equipment

 

across

 

Europe,

 

New

 

Zealand

 

and

 

Australia


Expected

 

full

 

year

 

capital

 

expenditure

 

~$60

 

million

Below

 

initial

 

expectations

 

as

 

land

 

settlements

 

likely

 

in

 

the

 

2019

 

financial

 

year

First Half Review
A

 

difficult

 

first

 

half;

 

less

 

than

 

satisfactory

 

performance

 

in

 

Asia

 

and

 

Americas

Inhibitors

 

included:

Region

EBITDA

 

Impact


Easter

 

trading

 

effect

 

NZ/AU

NZ$2.8

 

million


Kaikoura earthquake

 

transit

 

issues

NZ

NZ$3.0

 

million


Air

 

freight

 

tonnage

 

reduction

AS/US

US$3.7

 

million


Establishment

 

costs

 

of

 

new

 

warehouse

EU

EU€0.6

 

million


Software

 

implementation

 

NZ/EU

NZ$1.1

 

million


Sales

 

growth

 

of

 

7.3%


Strong

 

market

 

share

 

gains

 

and

 

profitability

 

in

 

Australia


September/October

 

improved

 

trading

 

in

 

all

 

regions

Half Year Analysis: Revenue
$000

THIS

 

YEAR

LAST

 

YEAR

VARIANCE

New Zealand:

 

NZ$

316,867

287,546

10.2%


Australia:

 

AU$

292,914

257,650

13.7%


USA:

 

US$

203,058

226,097

(10.2)%


Asia*:

 

US$

37,612

31,448

19.6%


Europe:

 

EU€

162,511

136,475

19.1%


Total

 

Group:

 

NZ$

1,225,583

1,142,437

7.3%


(excl FX)

 

7.4%


*

 

Inter


company

 

totalled

 

US$19.10

 

million

 

for

 

Asia,

 

down

 

from

 

US$33.54

 

million

Revenue

 

including

 

inter


company

 

for

 

is

 

Asia

 

down

 

12.7%

Half Year Analysis: EBITDA
$000

THIS

 

YEAR

LAST

 

YEAR

VARIANCE

New Zealand:

 

NZ$

38,446

37,163

3.5%


Australia:

 

AU$

20,829

16,092

29.4%


USA:

 

US$

8,442

9,812

(14.0)%


Asia:

 

US$

2,025

4,729

(52.7)%


Europe:

 

EU€

8,403

7,650

9.8%


Total

 

Group:

 

NZ$

88,766

86,348

2.8%


(excl FX)

 

2.8%

New Zealand

Revenue

 

growth

 

continues

 

to

 

be

 

dominated

 

by

 

Transport

 


Excluding

 

Disruption

 

Surcharge,

 

revenue

 

increase

 

at

 

6.5%


EBITDA

 

improvement

 

across

 

all

 

divisions,

 

however

 

subdued

 

in

 

Transport

 

as:


Inter


Island

 

volumes

 

decline


Higher

 

roading costs

 

for

 

inter


island

 

volume


Increased

 

labour

 

costs

 

for

 

inter


island

 

movements


Costs

 

associated

 

with

 

software

 

implementation

Revenue:

 

$317m

     

10.2%

EBITDA:

 

$39m

  

3.5%

New Zealand

Transport


Continues

 

to

 

gain

 

market

 

share


Commencement

 

of

 

rail

 

services

 

(first

 

week

 

of

 

November)


Pre


Christmas

 

volumes

 

very

 

strong


Expectations

 

of

 

a

 

strong

 

second

 

half


Prior

 

year

 

second

 

half

 

impacted

 

by

 

earthquake


Logistics


Opened

 

additional

 

warehouse

 

in

 

Christchurch

 

to

 

offset

 

inter


island

 

freight

 

delays/supply

 

chain

 

efficiencies


Utilisation

 

and

 

activity

 

levels

 

strong

 

leading

 

into

 

Christmas


Air

 

&

 

Ocean


Revenue

 

levels

 

up

 

year

 

on

 

year


Import

 

volumes

 

continue

 

to

 

outweigh

 

exports

Australia

Strong

 

sales

 

and

 

EBITDA

 

growth

 

in

 

Transport

 

and

 

Logistics;

 

Air

 

&

 

Ocean

 

sales

 

growth

 

and

 

EBITDA

 

contribution

 

muted

 


Transport


Sales

 

growth

 

strong


Net

 

margin

 

improvements


Market

 

share

 

gains

 

as

 

quality

 

of

 

service

 

increases


Expansion

 

of

 

network


Bendigo,

 

November

 

2017


Toowoomba,

 

early

 

in

 

2018


Cautious

 

about

 

management

 

of

 

volumes

 

through

 

peak

 

period

Revenue:

 

$293m

     

13.7%

EBITDA:

 

$21m

  

29.4%

Australia

Logistics


Activity

 

and

 

utilisation

 

levels

 

continue

 

to

 

improve


Land

 

acquisition

 

remains

 

high

 

on

 

agenda


Melbourne

 

x2


Adelaide


Brisbane

 

(leased)


Sales

 

growth

 

continues


Air

 

&

 

Ocean


Sales

 

growth

 

less

 

than

 

expected


Focus

 

on

 

Mainfreight

 

trade


lane

 

development

 

continues


Expectation

 

of

 

improving

 

performance

The Americas

Disappointed

 

at

 

lack

 

of

 

overall

 

progress


Trading

 

expectations

 

across

 

all

 

3

 

divisions

 

did

 

not

 

materialise;

 

small

 

improvements

 

in

 

October


Domestic


Sales

 

gains

 

in

 

every

 

day

 

freight

 

has

 

not

 

adequately

 

replaced

 

freight

 

forwarding

 

losses


Strong

 

focus

 

on

 

getting

 

six

 

key

 

hubs

 

profitable


Logistics


Customer

 

gains

 

continue;

 

Newark

 

facility

 

benefiting


New

 

warehouse

 

for

 

Chicago

 

–leased

 

– 20,000m

2

Revenue:

 

$203m

     

(10.2)%

EBITDA:

 

$8m

  

(14.0)%

The Americas

Air

 

&

 

Ocean


If

 

abnormal

 

prior

 

year

 

airfreight

 

account

 

excluded,

 

shows

 

market

 

share

 

gains,

 

just

 

not

 

quickly

 

enough


CaroTrans revenue

 

decline

 

halted


Focus

 

on

 

core

 

USA

 

branch

 

improvements

 

in

 

profit

 

and

 

quality

Asia

EBITDA

 

performance

 

yet

 

to

 

improve

 

from

 

year

 

end

 

2017


In


country

 

revenue

 

gains

 

are

 

at

 

lower

 

margins


Loss

 

of

 

inter


company

 

airfreight

 

revenue

 

(USA)

 

impacted

 

margins


Senior

 

management

 

change

 

brings

 

strong

 

focus

 

on

 

branch

 

profitability

 

improvements

Revenue:

 

$38m 19.6%

EBITDA:

 

$2m

  

(52.7)%

Europe

Pleasing

 

revenue

 

improvement

 

across

 

all

 

three

 

divisions


Logistics


Successfully

 

implemented

 

new

 

warehouse

 

(NL)

 

in

 

June;

 

new

 

warehouse

 

opened

 

in

 

Ghent

 

(BE)

 

in

 

September


Sales

 

pipeline/customer

 

gains

 

provide

 

further

 

confidence


New

 

warehouse

 

in

 

Born

 

(NL)

 

will

 

open

 

in

 

March

 

2018

Revenue:

 

€163m 19.1%

EBITDA:

 

€8m 9.8%

Europe

Forwarding/Transport

 


Revenue

 

growth

 

contributed

 

to

 

operational

 

pressure


Network

 

capacity

 

issues

 

throughout

 

Europe

 

on

 

the

 

increase

 

–rate

 

reviews

 

underway


New

 

dock

 

in

 

Genk

 

(BE)

 

to

 

assist

 

cross


dock

 

congestion

 

in

 

‘s


Heerenberg


Air

 

&

 

Ocean


Revenue

 

growth

 

in

 

both

 

imports

 

and

 

exports


USA

 

heavily

 

weighted;

 

Asia

 

growing


Network

 

expansion

 

in

 

Italy;

 

further

 

branches

 

likely

 

to

 

open

 

in

 

Germany

 

in

 

2018

Group Outlook
Indicators

 

for

 

first

 

five

 

weeks

 

of

 

second

 

half

 

show

 

further

 

profit

 

improvement


The

 

inhibitors

 

present

 

in

 

the

 

first

 

half

 

are

 

reduced/eliminated


Expectations

 

are

 

for

 

a

 

stronger

 

second

 

half

 

versus

 

the

 

prior

 

comparative

 

period


Confidence

 

of

 

an

 

improved

 

full

 

year

 

result

Financial Calendar F17
DATE

F18 – 12

 

months

 

ended

 

31

 

March

 

2018

29

 

May

 

2018

Taking expressions

 

of

 

interest

 

for

 

Europe

 

Investor

 

Day

20 June

 

2018

Annual

 

Meeting

 

of

 

Shareholders

26

 

July

 

2018

F19

 

–6

 

months

 

ended

 

30

 

September

 

2018

14

 

November

 

2018

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • AFT — AFT Pharmaceuticals Limited: Interim Report FY2018
    2017-11-22

    GROUP OPERATING RESULTS Six month period ended 30 September Change ($) Change (%) $NZ000’s FY2018 FY2017 Revenue36,56129,787 +6,774+23 Cost of Sales(22,256) (19,018) +3,238+17 Gross Profit14,305 10,769 +3,536+33 Other income1,014 1,007 +7+1 Selling and distribution expens…”

  • AFT — AFT Pharmaceuticals Limited: FY2018 H1 Update Presentation
    2017-11-22

    Investor Presentation November 2017 •23% growth in Group operating revenue •Strong Over-the-counter growth in Australia •Strong Hospital sales in Australia with successes in tenders •Good Over-the-counter growth in New Zealand •C rystaderm line extensions launched in New…”

  • AFT — AFT Pharmaceuticals Limited: FY2018 H1 Updated Presentation
    2017-11-23

    Investor Presentation November 2017 •23% growth in Group operating revenue •Strong Over-the-counter growth in Australia •Strong Hospital sales in Australia with successes in tenders •Good Over-the-counter growth in New Zealand •C rystaderm line extensions launched in New…”